Synergistic Activation of Immunogenic Cell Death and the cGAS-STING Pathway by Engineered Zinc/Manganese-Based

Bingzi Zhu1,2,3, Xiaodong Chen1,2,3, Chang Xu1,2,3

  • 1Department of Colorectal and Anal Surgery, Zhejiang-Finland Joint Laboratory of Gastrointestinal Tumor Metabolism and Nutrition, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.

Insights

Engineered nanoparticles activate the cyclic GMP-AMP synthase-stimulator of interferon genes (cGAS-STING) pathway and induce immunogenic cell death (ICD) to enhance antitumor immunity. This approach shows promise for colon cancer treatment, especially when combined with immune checkpoint blockade.

Area of Science:

  • Immunology
  • Nanotechnology
  • Cancer Therapy

Background:

  • The cyclic guanosine monophosphate (GMP)-adenosine monophosphate (AMP) synthase-stimulator of interferon genes (cGAS-STING) pathway is vital for anti-tumor immunity.
  • Activating the cGAS-STING pathway alone is often insufficient to eradicate established tumors.
  • Developing strategies to enhance cGAS-STING pathway activation and overcome tumor immunosuppression is critical.

Purpose of the Study:

  • To engineer novel zinc/manganese (Zn/Mn)-based metal-organic framework (MOF) nanoparticles (AMP@Zn/Mn-MOF) for enhanced antitumor immune responses.
  • To investigate the therapeutic potential of AMP@Zn/Mn-MOF in activating the cGAS-STING pathway and inducing immunogenic cell death (ICD).
  • To evaluate the efficacy of AMP@Zn/Mn-MOF in combination with immune checkpoint blockade for colon cancer treatment.

Main Methods:

  • Fabrication of AMP@Zn/Mn-MOF nanoparticles encapsulating the STING agonist c-di-AMP diammonium.
  • Assessment of cGAS-STING pathway activation and innate immune response facilitation by AMP@Zn/Mn-MOF.
  • Evaluation of AMP@Zn/Mn-MOF's peroxidase (POD)-mimetic and glutathione oxidase (GSHox)-mimetic activities.
  • Investigation of AMP@Zn/Mn-MOF's ability to induce immunogenic cell death (ICD) and reprogram the tumor microenvironment.
  • Testing the therapeutic efficacy of AMP@Zn/Mn-MOF in murine MC38 tumor models and in combination with anti-programmed death ligand 1 (αPD-L1) therapy.

Main Results:

  • AMP@Zn/Mn-MOF nanoparticles effectively activated the cGAS-STING pathway and innate immunity.
  • The nanoparticles exhibited POD-mimetic and GSHox-mimetic activities, potentiating tumor cell death and inducing ICD.
  • AMP@Zn/Mn-MOF reprogrammed the immunosuppressive tumor microenvironment by increasing lymphocyte infiltration.
  • Significant suppression of murine MC38 tumor growth was observed with AMP@Zn/Mn-MOF treatment.
  • Combination therapy with AMP@Zn/Mn-MOF and αPD-L1 blockade resulted in amplified antitumor effects and an abscopal effect against distant tumors.

Conclusions:

  • AMP@Zn/Mn-MOF serves as a promising nanoplatform for enhancing antitumor immunity via cGAS-STING pathway activation and ICD induction.
  • This nanoplatform effectively reprograms the tumor microenvironment and synergizes with immune checkpoint blockade.
  • Enhanced immune checkpoint blockade-based immunotherapy using AMP@Zn/Mn-MOF holds significant potential for colon cancer treatment.

Related Concept Videos

Metallic Solids02:37

Metallic Solids

Metallic solids such as crystals of copper, aluminum, and iron are formed by metal atoms. The structure of metallic crystals is often described as a uniform distribution of atomic nuclei within a “sea” of delocalized electrons. The atoms within such a metallic solid are held together by a unique force known as metallic bonding that gives rise to many useful and varied bulk properties.
All metallic solids exhibit high thermal and electrical conductivity, metallic luster, and malleability....
20.6K
Eukaryotic Transcription Activators02:42

Eukaryotic Transcription Activators

Transcription activators are proteins that promote the transcription of genes from DNA to RNA. In most cases, these proteins contain two separate domains ‒ a domain that binds to DNA and a domain for activating transcription; however, in some cases, a single domain is responsible for both binding and activation of transcription, as seen in the glucocorticoid receptor and MyoD.
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These...
12.8K
The Colonization of Land02:22

The Colonization of Land

Changes in the environment of the early Earth drove the evolution of organisms. As prokaryotic organisms in the oceans began to photosynthesize, they produced oxygen. Eventually, oxygen saturated the oceans and entered the air, resulting in an increase in atmospheric oxygen concentration, known as the oxygen revolution approximately 2.3 billion years ago. Therefore, organisms that could use oxygen for cellular respiration had an advantage. More than 1.5 years ago, eukaryotic cells and...
37.6K
Batteries and Fuel Cells03:12

Batteries and Fuel Cells

A battery is a galvanic cell that is used as a source of electrical power for specific applications. Modern batteries exist in a multitude of forms to accommodate various applications, from tiny button batteries such as those that power wristwatches to the very large batteries used to supply backup energy to municipal power grids. Some batteries are designed for single-use applications and cannot be recharged (primary cells), while others are based on conveniently reversible cell reactions that...
30.9K
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
4.5K
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
9.8K